Press Release

Rising Prevalence of Cancer Cases Promoting the Growth of the North America Virtual Clinical Trials Market

North America Virtual Clinical Trials market is anticipated to grow at an astronomical rate owing to the surging incidences of cancer cases in the US and Canada, burgeoning adoption of telehealth technologies such as like remote patient monitoring and wearable mHealth devices, and boost in R&D expenditure. Moreover, the booming elderly population, rising incidences of neurological diseases such as Alzheimer’s and tumors, and globalization of virtual clinical trials are some of the factors projected to upsurge the growth of North America virtual clinical trials market in the forthcoming years.

According to MarkNtel Advisors’ research report titled “North America Virtual Clinical Trials Market Analysis, 2020”, the North America Virtual Clinical Trials market is anticipated to grow at a considerable CAGR during 2020-25. Based on Application, Oncology segment acquired the majority market share in the North America virtual clinical trial market in 2019. The burgeoning aging population, rising prevalence of cancer cases, and growing researcher inclination toward the development of new cancer treatments are some of the factors driving the growth of the segment.

“North America Virtual Clinical Trials Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Virtual Clinical Trials providers across the region. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.      

Canada Exhibited Significant Growth

Canada grew at a significant rate in 2019 owing to an upsurge in the number of cardiovascular diseases among people, an increase in the investment by the pharma companies of R&D activities, and burgeoning partnerships between pharmaceutical and clinical research organizations. Besides these, growing digitalization in healthcare infrastructure, increasing per capita income, and favorable government initiatives are expected to accelerate the growth of the Virtual Clinical Trials Market in the forthcoming period as stated in MarkNtel Advisors’ research report “North America Virtual Clinical Trials Market Analysis, 2020”. 

According to MarkNtel Advisors’ the key players with a considerable market share in the North America Virtual Clinical Trials market are ICON Plc, Clinical Ink, Inc., Science 37, Inc., Medable, Inc., Medidata Solutions, Signant Health (CRF Health), PRA Health Sciences, Oracle Corporation, Covance, Inc., Parexel International etc.

Market Segmentation:

1. By Type (Interventional Trials, Expanded Access Trials, Observational Trials)
2. By Application (Cardiovascular Disease, Oncology, Others)
3. By Country (The US, Canada, Mexico),
4. By Company (ICON Plc, Clinical Ink, Inc., Science 37, Inc., Medable, Inc., Medidata Solutions, Signant Health (CRF Health), PRA Health Sciences, Oracle Corporation, Covance, Inc., Parexel International etc.)

Key questions answered in the study:

1. What are the current and future trends of the Virtual Clinical Trials industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Virtual Clinical Trials industry?
5. What is the customer orientation, purchase behavior, and expectations from the Virtual Clinical Trials firms across various regions?